On Friday 14th July, the Government published its new Drug Strategy: ‘2017 Drug Strategy’. The previous drug strategy, published in 2010, was heavily criticised for its almost exclusive focus on abstinence, and total de-prioritisation of harm reduction initiatives.
This briefing, endorsed by eight of the UK’s leading harm reduction and drug treatment organisations, looks at whether the focus on harm reduction has improved under the new strategy, and discusses challenges in the funding environment which will have a disproportionate impact on harm reduction services.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.
Thumbnail: Flickr CC